Vertex Innovation Awards
The Vertex Innovation Awards fund impactful, collaborative clinical research projects to improve care for people with cystic fibrosis.
Funder: Vertex Pharmaceuticals
Due Dates (Anticipated): December 2026 (full application deadline; next award cycle projected)
Funding Amounts: Up to $750,000 USD per project; up to four awards annually; typically one-year duration.
Summary: Supports innovative, collaborative clinical research to improve care for people with cystic fibrosis (CF).
Key Information: This is a projected/forecasted cycle—dates may shift; check the program page for updates.
Description
The Vertex Innovation Awards (VIA) provide significant funding to support innovative and collaborative clinical research projects that aim to advance the care of people living with cystic fibrosis (CF). The program welcomes applications from across the CF research field, with projects led by individuals who have an established career interest in CF. Each year, up to four projects are selected and each may receive up to $750,000 USD. The awards are intended to drive high-impact clinical research and are selected by an independent committee of external experts.
